Publications by authors named "Ester Moncho Escriva"
Infection remains the Achilles heel of left ventricular assist device (LVAD) therapy. However, an optimal antimicrobial surgical infection prophylaxis (SIP) regimen has not been established. This study evaluated the efficacy of a single-drug SIP compared to a multi-drug SIP on clinical outcomes in patients undergoing continuous-flow LVAD (CF-LVAD) and pulsatile LVAD (P-LVAD) implantation.
View Article and Find Full Text PDFArticle Synopsis
- A systematic review and meta-analysis was conducted to compare outcomes of infections related to continuous-flow left ventricular assist devices (CF-LVAD), focusing on device exchange versus non-exchange treatments.
- The study analyzed 13 research articles with a total of 158 infection cases, revealing that 11.4% of patients underwent device exchange while 88.6% received non-exchange treatments.
- Findings showed no significant differences in overall mortality (17.6% for exchange vs. 23.3% for non-exchange) or infection recurrence rates (26.7% for exchange vs. 38.6% for non-exchange), suggesting device exchange does not provide a clear benefit.
The aim of this systematic review and meta-analysis was to evaluate the outcomes of concomitant mitral valve surgery for significant preexisting mitral regurgitation (MR) in patients undergoing continuous-flow left ventricular assist device (CF-LVAD) implantation. Electronic search was performed to identify all studies in the English literature examining concurrent mitral valve surgery in patients with CF-LVAD implantation. Identified articles were systematically assessed for inclusion and exclusion criteria.
View Article and Find Full Text PDFBackground: Transplant coronary artery vasculopathy (TCAV) is the major cause of late allograft failure and death in heart transplant recipients. The aim of this systematic review was to examine the outcomes of percutaneous coronary interventions (PCIs) as compared to coronary artery bypass grafting (CABG) surgery in the management of TCAV. Our secondary objective was to compare the use and outcomes of drug eluting stents (DES) as compared to bare metal stents (BMS) in this patient population.
View Article and Find Full Text PDFBackground: Long-term efficacy of heart retransplantation (RTx) for end-stage cardiac allograft failure remains unclear given the limited worldwide experience and is an important question to elucidate given the shortage of donor organs. The aim of this systematic review was to examine the outcomes of RTx in patients with cardiac allograft failure.
Methods: Electronic search was performed to identify all studies in the English literature assessing RTx for cardiac allograft failure.